Arvinas Inc (ARVN) concluded trading on Thursday at a closing price of $7.23, with 16.79 million shares of worth about $121.38 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -73.34% during that period and on May 01, 2025 the price saw a loss of about -24.84%. Currently the company’s common shares owned by public are about 68.80M shares, out of which, 59.90M shares are available for trading.
Stock saw a price change of -20.90% in past 5 days and over the past one month there was a price change of 2.84%. Year-to-date (YTD), ARVN shares are showing a performance of -62.28% which decreased to -77.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.93 but also hit the highest price of $37.38 during that period. The average intraday trading volume for Arvinas Inc shares is 2.36 million. The stock is currently trading -8.44% below its 20-day simple moving average (SMA20), while that difference is down -31.03% for SMA50 and it goes to -64.50% lower than SMA200.
Arvinas Inc (NASDAQ: ARVN) currently have 68.80M outstanding shares and institutions hold larger chunk of about 103.39% of that.
The stock has a current market capitalization of $497.22M and its 3Y-monthly beta is at 2.23. It has posted earnings per share of -$2.08 in the same period. It has Quick Ratio of 4.64 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARVN, volatility over the week remained 7.51% while standing at 7.76% over the month.
Stock’s fiscal year EPS is expected to drop by -16.63% while it is estimated to decrease by -19.55% in next year. EPS is likely to shrink at an annualized rate of -10.23% for next 5-years, compared to annual growth of -5.32% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on March 13, 2025 offering a Neutral rating for the stock and assigned a target price range of between $70 and $15 to it. Coverage by Wedbush stated Arvinas Inc (ARVN) stock as a Neutral in their note to investors on March 12, 2025, suggesting a price target of $12 for the stock. On March 11, 2025, Oppenheimer Downgrade their recommendations, while on December 10, 2024, BTIG Research Initiated their ratings for the stock with a price target of $69. Stock get an Overweight rating from Stephens on November 18, 2024.
